Literature DB >> 17127809

Prognostic role of alveolar-arterial oxygen pressure difference in acute pulmonary embolism.

Jen Te Hsu1, Chi Ming Chu, Shih Tai Chang, Hui Wen Cheng, Nye Jan Cheng, Wan-Ching Ho, Chang Min Chung.   

Abstract

BACKGROUND: This study investigated the utility of the alveolar - arterial oxygen pressure difference (AaDO (2)) in predicting the short-term prognosis of acute pulmonary embolism (PE). METHODS AND
RESULTS: This study retrospectively enrolled 114 consecutive patients with acute PE, diagnosed by either spiral computed tomography or high probability ventilation - perfusion lung scans. During the first 24 h of admission, all patients had initial artery blood gas collected under room air. Patient exclusion criteria were chronic lung disease, septic emboli, and moderate and low probability lung scans. Patients were assigned to 2 groups based on either 30-day death or a 30-day composite event. Receiver operating characteristic analyses was used to determine the AaDO(2) cut-off value for predicting primary and composite endpoints. Statistical analysis demonstrated significant differences in AaDO(2) between the 30-day composite endpoint group and the 30-day composite event-free survival group (p=0.012). The AaDO(2) had a strong trend between the 30-day death group and the survival group (p=0.062). The best cut-off value for AaDO(2) was 53 mmHg and using this, the positive predictive value for 30-day death was 25% and the negative predictive value was 92%. For the 30-day composite endpoint, the positive predictive value for AaDO(2) was 35%, and the negative predictive value was 84%. In this study, thrombocytopenia was also an indicator of poor prognosis for patients with acute PE.
CONCLUSION: The AaDO(2) measurement is a highly useful and simple measurement for predicting short-term prognosis in patients with acute PE. It has high negative predictive value and moderate positive predictive value for 30-day death and 30-day composite event. Aggressive thrombolytic treatment strategies should be considered for patients with an initial poor prognostic parameter (ie, AaDO(2) >or=53 mmHg).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17127809     DOI: 10.1253/circj.70.1611

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  8 in total

1.  Heart rate in pulmonary embolism.

Authors:  Karsten Keller; Johannes Beule; Meike Coldewey; Wolfgang Dippold; Jörn Oliver Balzer
Journal:  Intern Emerg Med       Date:  2015-01-30       Impact factor: 3.397

2.  Risk stratification in submassive pulmonary embolism via alveolar-arterial oxygen gradient.

Authors:  O Ince; N Altintas; S Findik; M Sariaydin
Journal:  Hippokratia       Date:  2014 Oct-Dec       Impact factor: 0.471

3.  Clinical application of the Innovance D-dimer assay in the diagnosis of acute pulmonary thromboembolism.

Authors:  Zhuxiao Bai; Yurong Huang; Chenghua Song; Huimin Liu; Yihui Chen; Haitao Zhang; Xinhong Lu; Yingbo Song; Xin Zhang
Journal:  Exp Ther Med       Date:  2017-04-28       Impact factor: 2.447

4.  Impact of advanced age on the severity of normotensive pulmonary embolism.

Authors:  Karsten Keller; Johannes Beule; Meike Coldewey; Wolfgang Dippold; Jörn Oliver Balzer
Journal:  Heart Vessels       Date:  2014-06-19       Impact factor: 2.037

5.  Effect of simvastatin on the SIRT2/NF-κB pathway in rats with acute pulmonary embolism.

Authors:  Zhi-Yao Wu; Hui Li; Yong-Jun Tang
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

6.  Relationship between Thrombosis Risk Factors, Clinical Symptoms, and Laboratory Findings with Pulmonary Embolism Diagnosis; a Cross-Sectional Study.

Authors:  Rama Bozorgmehr; Mehdi Pishgahi; Pegah Mohaghegh; Marziye Bayat; Parastou Khodadadi; Ahmadreza Ghafori
Journal:  Arch Acad Emerg Med       Date:  2019-07-23

Review 7.  Prognostic stratification of acute pulmonary embolism: focus on clinical aspects, imaging, and biomarkers.

Authors:  Luca Masotti; Marc Righini; Nicolas Vuilleumier; Fabio Antonelli; Giancarlo Landini; Roberto Cappelli; Patrick Ray
Journal:  Vasc Health Risk Manag       Date:  2009-07-14

8.  Impact of cancer on the effectiveness of cardiac Troponin I to predict right ventricular dysfunction in acute pulmonary embolism.

Authors:  Karsten Keller; Martin Geyer; Johannes Beule; Meike Coldewey; Jörn Oliver Balzer; Wolfgang Dippold
Journal:  Thorac Cancer       Date:  2015-01-22       Impact factor: 3.500

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.